Amorphex Therapeutics Holdings Inc
Amorphex Therapeutics Holdings Inc, based in Andover, MA, is pioneering advancements in ocular drug delivery with its patented device, TODD, designed to deliver medication to the eye continuously for extended periods. This innovative platform addresses the challenges of traditional eyedrop therapy, offering a non-invasive solution that enhances patient adherence and reduces side effects.
The TODD device is comfortably worn under the eyelid and can be easily replaced at prescribed intervals, making it a practical alternative for treating various ophthalmic diseases, including glaucoma. Additionally, the technology opens up new possibilities for treating conditions where conventional drops are ineffective, such as retinal diseases and myopia progression.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.



